Tempus AI valued at $446,275,249 in Cathie Wood’s portfolio
Tempus AI Inc. is a healthcare diagnostics and data platform that utilizes AI tools to aid physicians in treatment decisions.
The company has accumulated over 450 petabytes of clinical and genomic data, enhancing the accuracy of its AI models.
Management estimates that expanding into ECG-based testing could generate over $200 million in annual revenue, significantly increasing its revenue base.
With 200 million potential for growth, Tempus AI is a key player in the AI healthcare sector.